Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health

FSG’s co-founder, Professor Michael E. Porter of Harvard Business School, presented a first look at the new research that will directly impact the pharmaceutical and medical device industries. Please visit the Competing by Saving Lives event page for an event synopsis, including the full agenda and speakers, executive video insights, a list of participating corporations, and access to Michael Porter’s keynote slide presentation.

Read Competing by Saving Lives Report and Executive Summary

"Competing by Saving Lives" examines how pharmaceutical and medical device companies can create shared value in global health by addressing unmet health needs in low and middle-income countries. The report notes numerous examples of companies that are creating shared value in global health, and profiles ten in detail: GE, Abbott, Stryker, AstraZeneca, Medtronic, Novartis, Novo Nordisk, GlaxoSmithKline, Eli Lilly and Company, and Becton Dickinson and Company.

The unmet health needs of billions of underserved patients represent an untapped potential for innovation and growth. Research demonstrates that companies have already begun to reap business value and are securing competitive advantages in new markets by transforming their products, pricing, manufacturing, distribution, and marketing to profitably meet these needs.

FSG would like to thank the following sponsors for their support and contributions to FSG's work on Shared Value in Global Health: Abbott, Becton Dickinson and Company, Eli Lilly and Company, and Medtronic.

For media inquiries, and to connect with shared value in global health experts, please contact Michelle Morgan-Nelsen at FSG.